Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TransTechnology
High Point, North Carolina, USA
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
vTv Therapeutics (formerly TransTech Pharma) is a clinical-stage pharmaceutical company focused on developing oral small molecule drug candidates for metabolic and inflammatory diseases. The company's lead program, cadisegliatin (TTP399), is a liver-selective glucokinase activator being developed as an adjunctive therapy to insulin for Type 1 diabetes. vTv Therapeutics utilizes its proprietary drug discovery platform, TTP Translational Technology, to identify and develop novel therapies. The company has established several strategic partnerships to advance its pipeline, including collaborations with G42 Healthcare and Cantex Pharmaceuticals.
- Therapeutic areas
- EndocrinologyNeurologyDermatologyPulmonologyOncology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
G42 HealthcareCantex PharmaceuticalsHangzhou Zhongmei Huadong Pharmaceutical
Beyond the preview
Go deeper on TransTechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TransTechnology.